185 related articles for article (PubMed ID: 15984343)
41. Feline immunodeficiency virus diagnosis after vaccination.
Andersen PR; Tyrrell P
Anim Health Res Rev; 2004 Dec; 5(2):327-30. PubMed ID: 15984349
[TBL] [Abstract][Full Text] [Related]
42. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
Coleman JK; Pu R; Martin MM; Noon-Song EN; Zwijnenberg R; Yamamoto JK
Vaccine; 2014 Feb; 32(6):746-54. PubMed ID: 23800540
[TBL] [Abstract][Full Text] [Related]
43. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
Bęczkowski PM; Harris M; Techakriengkrai N; Beatty JA; Willett BJ; Hosie MJ
Vaccine; 2015 Feb; 33(8):977-84. PubMed ID: 25613718
[TBL] [Abstract][Full Text] [Related]
44. Passive antibody protection of cats against feline immunodeficiency virus infection.
Hohdatsu T; Pu R; Torres BA; Trujillo S; Gardner MB; Yamamoto JK
J Virol; 1993 Apr; 67(4):2344-8. PubMed ID: 8383246
[TBL] [Abstract][Full Text] [Related]
45. FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.
Hofmann-Lehmann R; Holznagel E; Aubert A; Bauer-Pham K; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):115-25. PubMed ID: 7618251
[TBL] [Abstract][Full Text] [Related]
46. The development of a vaccine against feline immunodeficiency virus.
Hosie MJ
Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
[TBL] [Abstract][Full Text] [Related]
47. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
[TBL] [Abstract][Full Text] [Related]
48. Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines.
Tellier MC; Soos J; Pu R; Pollock D; Yamamoto JK
Vet Microbiol; 1997 Jun; 57(1):1-11. PubMed ID: 9231977
[TBL] [Abstract][Full Text] [Related]
49. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax
Westman M; Norris J; Malik R; Hofmann-Lehmann R; Parr YA; Armstrong E; McDonald M; Hall E; Sheehy P; Hosie MJ
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546485
[TBL] [Abstract][Full Text] [Related]
50. Mucosal infection and vaccination against feline immunodeficiency virus.
Stokes CR; Finerty S; Gruffydd-Jones TJ; Sturgess CP; Harbour DA
J Biotechnol; 1999 Aug; 73(2-3):213-21. PubMed ID: 10486930
[TBL] [Abstract][Full Text] [Related]
51. Use of a feline panleukopenia modified live virus vaccine in cats in the primary-stage of feline immunodeficiency virus infection.
Buonavoglia C; Marsilio F; Tempesta M; Buonavoglia D; Tiscar PG; Cavalli A; Compagnucci M
Zentralbl Veterinarmed B; 1993 Jul; 40(5):343-6. PubMed ID: 8237206
[TBL] [Abstract][Full Text] [Related]
52. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
[TBL] [Abstract][Full Text] [Related]
53. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
Hosie MJ; Dunsford T; Klein D; Willett BJ; Cannon C; Osborne R; Macdonald J; Spibey N; Mackay N; Jarrett O; Neil JC
J Virol; 2000 Oct; 74(20):9403-11. PubMed ID: 11000209
[TBL] [Abstract][Full Text] [Related]
54. Vaccine protection against feline immunodeficiency virus: setting the challenge.
Hosie MJ; Beatty JA
Aust Vet J; 2007; 85(1-2):5-12; quiz 85. PubMed ID: 17300445
[TBL] [Abstract][Full Text] [Related]
55. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
[TBL] [Abstract][Full Text] [Related]
56. Feline immunodeficiency. ABCD guidelines on prevention and management.
Hosie MJ; Addie D; Belák S; Boucraut-Baralon C; Egberink H; Frymus T; Gruffydd-Jones T; Hartmann K; Lloret A; Lutz H; Marsilio F; Pennisi MG; Radford AD; Thiry E; Truyen U; Horzinek MC
J Feline Med Surg; 2009 Jul; 11(7):575-84. PubMed ID: 19481037
[TBL] [Abstract][Full Text] [Related]
57. New vaccine to fight feline FIV.
Aust Vet J; 2004 Dec; 82(12):730. PubMed ID: 15648930
[No Abstract] [Full Text] [Related]
58. AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus.
Matteucci D; Pistello M; Mazzetti P; Giannecchini S; Isola P; Merico A; Zaccaro L; Rizzuti A; Bendinelli M
Vaccine; 1999 Aug; 18(1-2):119-30. PubMed ID: 10501242
[TBL] [Abstract][Full Text] [Related]
59. Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells.
Karlas JA; Siebelink KH; v Peer MA; Huisman W; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):353-65. PubMed ID: 9839884
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic utility of CD4%:CD8 low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats.
Litster A; Lin JM; Nichols J; Weng HY
Vet Microbiol; 2014 Jun; 170(3-4):197-205. PubMed ID: 24559863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
